Invesco India Pharma and Healthcare Fund - Direct Plan - Growth

  • Scheme Category:  
  • Equity Scheme >  
NAV: ₹ 9.57 ↓ -0.21%
[as on 1 October, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of Invesco India Pharma and Healthcare Fund - Direct Plan - Growth and its peers as on 1 October, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
Invesco India Pharma and Healthcare Fund - Direct Plan - Growth- -0.21% -4.59%-------
Nippon India Banking & Financial Services Fund - Direct Plan Growth Plan - Growth Option -7.69% -0.2% -2.36% -5.58% -6.86% -1.79% 10.2% 12.12% 13.77% 12.61%
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option 10.34% -0.29% -2.87% -2.96% 0.79% 12.36% 17.62% 13.51% 23.05% 15.49%
Nippon India Power & Infra Fund - Direct Plan Growth Plan - Growth Option 5.09% -1.35% -3.26% -4.54% -5.29% 6.07% 16.98% 19.46% 22.25% 17.59%
DSP Healthcare Fund - Direct Plan - Growth 14.38% -0.41% -3.06% -3.45% 3.21% 15.61% 20.7% 15.23% 25.89%-
DSP Banking & Financial Services Fund - Direct - Growth -1.5% -0.91% -2.39% -7.87% -6.3% 5.81%----

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns----------

Discrete returns (monthly)

MonthDec 2025Jan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026Jul 2026Aug 2026Sep 2026
Returns----------

NAV history

Invesco India Pharma and Healthcare Fund - Direct Plan - Growth - 30 days NAV (Net asset value) history

DateNAV% change
1 October, 20269.57 -0.21%
30 September, 20269.59 -2.74%
29 September, 20269.86 0.1%
28 September, 20269.85 -1.1%
25 September, 20269.96 -0.7%
24 September, 202610.03 -0.69%
23 September, 202610.1 0.6%
22 September, 202610.04 -0.4%
21 September, 202610.08 0.3%
18 September, 202610.05 1.01%
17 September, 20269.95 0.71%
16 September, 20269.88 -0.2%
15 September, 20269.9 -0.9%
11 September, 20269.99 -0.3%
10 September, 202610.02

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of Invesco India Pharma and Healthcare Fund - Direct Plan - Growth?
    The latest NAV of Invesco India Pharma and Healthcare Fund - Direct Plan - Growth is 9.57 as on 1 October, 2026.
  • What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for Invesco India Pharma and Healthcare Fund - Direct Plan - Growth?
    Invesco India Pharma and Healthcare Fund - Direct Plan - Growth is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)
    Holding periodTax rate
    Less than 1 year (STCG)20%
    More than 1 year (LTCG)Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.